Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of acellular DTP (component) vaccine in healthy infants
CTR20251982Phase 3Active
- Sponsor
- Beijing Minhai Biological
- Start
- May 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed) in pertussis, diphtheria, Tetanus, sponsored by Beijing Minhai Biological. Started May 2025; status: active.
02
Drugs
diphtheria + tetanus + pertussis (acellular, component) vaccine (adsorbed)
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on CTR20251982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251982.